Search research articles
Contact Us
Filters
Showing results (101-110 of 161) with videos related to
Page
of 17
Sort By:
Thorax
|
February 27, 2013
Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial
William W Busse, Paul M O'Byrne, Eugene R Bleecker, et al.
The European Respiratory Journal
|
September 25, 2021
Short-acting β<sub>2</sub>-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
Eric D Bateman, David B Price, Hao-Chien Wang, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 4, 2009
Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing
Richard N van Zyl-Smit, Madhukar Pai, Kwaku Peprah, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 19, 2019
Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD
Courtney Crim, Michael L Watkins, Eric D Bateman, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 9, 2021
Reply to "As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function"
Helen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 10, 2015
Multimorbidity, control and treatment of noncommunicable diseases among primary healthcare attenders in the Western Cape, South Africa
Naomi Folb, Venessa Timmerman, Naomi S Levitt, et al.
The European Respiratory Journal
|
November 21, 2015
Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD
Helgo Magnussen, Kay Tetzlaff, Eric D Bateman, et al.
BMC Pulmonary Medicine
|
August 29, 2006
Diagnostic accuracy of an integrated respiratory guideline in identifying patients with respiratory symptoms requiring screening for pulmonary tuberculosis: a cross-sectional study
René G English, Max O Bachmann, Eric D Bateman, et al.
The Journal of Allergy and Clinical Immunology
|
September 27, 2014
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations
Eric D Bateman, Roland Buhl, Paul M O'Byrne, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 25, 2021
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma
Helen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 161) with videos related to
Sort By:
Page
of 17
Thorax
|
February 27, 2013
Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial
William W Busse, Paul M O'Byrne, Eugene R Bleecker, et al.
The European Respiratory Journal
|
September 25, 2021
Short-acting β<sub>2</sub>-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
Eric D Bateman, David B Price, Hao-Chien Wang, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 4, 2009
Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing
Richard N van Zyl-Smit, Madhukar Pai, Kwaku Peprah, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 19, 2019
Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD
Courtney Crim, Michael L Watkins, Eric D Bateman, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 9, 2021
Reply to "As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function"
Helen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 10, 2015
Multimorbidity, control and treatment of noncommunicable diseases among primary healthcare attenders in the Western Cape, South Africa
Naomi Folb, Venessa Timmerman, Naomi S Levitt, et al.
The European Respiratory Journal
|
November 21, 2015
Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD
Helgo Magnussen, Kay Tetzlaff, Eric D Bateman, et al.
BMC Pulmonary Medicine
|
August 29, 2006
Diagnostic accuracy of an integrated respiratory guideline in identifying patients with respiratory symptoms requiring screening for pulmonary tuberculosis: a cross-sectional study
René G English, Max O Bachmann, Eric D Bateman, et al.
The Journal of Allergy and Clinical Immunology
|
September 27, 2014
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations
Eric D Bateman, Roland Buhl, Paul M O'Byrne, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 25, 2021
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma
Helen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
Page
of 17